Enovix Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission on November 12, 2026, announcing the release of its financial results for the third fiscal quarter of 2026.

Key Highlights

  • Filing date: November 12, 2026, covering results for the third fiscal quarter of 2026.
  • Registrant: Enovix Corporation, a Delaware-incorporated company headquartered in Fremont, California.
  • Exchange listing: Common Stock (par value $0.0001 per share) trades on the Nasdaq Global Select Market under NASDAQ:ENVX.
  • Signed by: Ryan Benton, Interim Chief Executive Officer, on behalf of Enovix Corporation.
  • Exhibit attached: A press release dated November 12, 2026, containing the Q3 2026 financial results was filed as Exhibit 99.1.
  • Emerging growth company: The registrant indicated by check mark that it is not an emerging growth company, as reflected in the filing's cover page.

Enovix Discloses Q3 2026 Results Through Current Report Filing

Enovix Corporation, a Delaware company with principal executive offices located at 3501 W Warren Avenue, Fremont, California 94538, issued a current report on Form 8-K under Item 2.02, which covers results of operations and financial condition. The company disclosed that on November 12, 2026, it issued a press release announcing its financial results for the third fiscal quarter of 2026. The press release is attached to the filing as Exhibit 99.1.

According to the filing, the information contained in the current report and its attached exhibits "shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, as amended." The filing further states the information is not to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference. Ryan Benton, identified in the filing as Interim Chief Executive Officer, signed the report on November 12, 2026, on behalf of the registrant.

Enovix Corporation's common stock carries a par value of $0.0001 per share and is listed on the Nasdaq Global Select Market. The company's IRS Employer Identification Number is 85-3174357, and its Commission File Number is 001-39753. The filing includes a Cover Page Interactive Data File embedded within the Inline XBRL document, listed as Exhibit 104.

What Was Disclosed

Enovix Corporation filed an 8-K on November 12, 2026, reporting under Item 2.02 that it had issued a press release on that same date covering its third fiscal quarter 2026 financial results, with the press release attached as Exhibit 99.1.